FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RAFUTROMBOPAG
异名/同义词(Z)-5-(2-HYDROXY-3-(2-(3-METHYL-5-OXO-1-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-4(5H)-YLIDENE)HYDRAZINYL)PHENYL) FURAN-2-CARBOXYLIC ACID
2-FURANCARBOXYLIC ACID, 5-(3-((2Z)-2-(1,5-DIHYDRO-3-METHYL-5-OXO-1-(5,6,7,8-TETRAHYDRO-2-NAPHTHALENYL)-4H-PYRAZOL-4-YLIDENE)HYDRAZINYL)-2-HYDROXYPHENYL)-
HETROMBOPAG
HETROMBOPAG [WHO-DD]
RAFUTROMBOPAG
RAFUTROMBOPAG [INN]
SHR8735
SHR-8735
CAS登记号2600513-51-5
物质唯一标识(Unique Ingredient Identifier)9WGT51BDDL
分子式C25H22N4O5
国际化合物标识(International Chemical Identifier,InChI)BDGGFTDRPHKXFC-QYQHSDTDSA-N
SMILESo1c(ccc1-c2c(c(ccc2)N/N=C\3/C(=NN(C3=O)c4cc5CCCCc5cc4)C)O)C(=O)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System